XRF Delivers Strong Revenue and Profit Growth Driven by International Demand
XRF Scientific Limited (ASX: XRF) has reported solid financial performance for the March 2026 quarter, with revenue increasing to AU$15.8 million, up 13.8% year-on-year, and profit before tax rising 10.7% to AU$3.7 million. Year-to-date performance also remained strong, with revenue reaching AU$47.0 million and profit before tax of AU$11.2 million, reflecting continued operational momentum. Growth was primarily driven by international sales, particularly across Asian markets, alongside robust consumables demand and improved capital equipment sales, including strong activity in the gold sector. The Company reported a record March month, with elevated order volumes resulting in approximately AU$1.0 million in additional orders to be recognized in the June quarter. Operational expansion initiatives progressed, including the establishment of a new office in India to support further growth. Ongoing product development and increasing repeat orders are expected to support continued momentum into upcoming quarters.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
XRF Delivers Strong Revenue and Profit Growth Driven by International Demand
XRF Scientific Limited (ASX: XRF) has reported solid financial performance for the March 2026 quarter, with revenue increasing to AU$15.8 million, up 13.8% year-on-year, and profit before tax rising 10.7% to AU$3.7 million. Year-to-date performance also remained strong, with revenue reaching AU$47.0 million and profit before tax of AU$11.2 million, reflecting continued operational momentum. Growth was primarily driven by international sales, particularly across Asian markets, alongside robust consumables demand and improved capital equipment sales, including strong activity in the gold sector. The Company reported a record March month, with elevated order volumes resulting in approximately AU$1.0 million in additional orders to be recognized in the June quarter. Operational expansion initiatives progressed, including the establishment of a new office in India to support further growth. Ongoing product development and increasing repeat orders are expected to support continued momentum into upcoming quarters.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au